Evidence map›Paper›PMID 30867526›Full record

ArticleScientific reports2019

Corosolic acid isolated from Eriobotrya japonica leaves reduces glucose level in human hepatocellular carcinoma cells, zebrafish and rats.

Shuwen Xu, Gang Wang, Wei Peng, Yandi Xu, Yu Zhang, Ying Ge, Yue Jing, Zhunan Gong

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Article
  3. The beneficial Effects ofCurrent diabetes reviews · 2026
    Article
  4. Effects ofMolecules (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Glycogen overload transforms the liver.Acta biochimica et biophysica Sinica · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Activation of Insulin Signaling by Botanical Products.International journal of molecular sciences · 2021
    Review
  16. Article
  17. Epigenetic Regulation of NRF2/KEAP1 by Phytochemicals.Antioxidants (Basel, Switzerland) · 2020
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Shuwen XuCenter for New Drug Research and Development, College of Life Science, Nanjing Normal University, Nanjing, 210023, People's Republic of China.
Gang WangCenter for New Drug Research and Development, College of Life Science, Nanjing Normal University, Nanjing, 210023, People's Republic of China.
Wei PengCenter for New Drug Research and Development, College of Life Science, Nanjing Normal University, Nanjing, 210023, People's Republic of China.
Yandi XuCenter for New Drug Research and Development, College of Life Science, Nanjing Normal University, Nanjing, 210023, People's Republic of China.
Yu ZhangCenter for New Drug Research and Development, College of Life Science, Nanjing Normal University, Nanjing, 210023, People's Republic of China.
Ying GeCenter for New Drug Research and Development, College of Life Science, Nanjing Normal University, Nanjing, 210023, People's Republic of China.
Yue JingCentral Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, 210008, People's Republic of China. jingyueshadow@126.com.
Zhunan GongCenter for New Drug Research and Development, College of Life Science, Nanjing Normal University, Nanjing, 210023, People's Republic of China. gongzhunan@njnu.edu.cn.
Nanjing Normal University · CNNanjing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes (T2D) with high morbidity and mortality is characterized by abnormal glucose and lipid metabolism due in part to insulin resistance in liver, which lead to elevated hyperglycemia and hyperlipidemia. This study sough to explore the effects of corosolic acid (CA) in different T2D models and explored the underlying mechanism. Separated from Eriobotrya japonica leaves, CA purity was above 95% measured by a HPLC method. Compared with cAMP and DEX induced T2D HepG2 model, CA significantly stimulated glucose consumption and improved glycogen accumulation by inhibiting PEPCK mRNA expression. And in cAMP and DEX induced T2D zebrafish model, CA reduced glycogen degradation and increased glucose consumption by regulating some key enzymes in carbon metabolism including GLUT1, GLUT2, GLUT3, LDHA, LDHB, GP, G6Pase, GYS1, and PFKFB3. In addition, insulin receptor signals were also involved in CA-regulated hypoglycemic action. Furthermore, in STZ-induced T2D rat model, compared with diabetic control groups, CA remarkably downregulated the levels of serum lipid, blood glucose, ICAM-1, malonaldehyde and insulin resistance index, while upregulated SOD activity and impaired glucose tolerance. In a conclusion, CA can regulate glucose and lipid metabolic adaptation in T2D like HepG2, zebrafish and rat models partly through reducing inflammation and oxidative stress and suppressing PEPCK.

Indexed as

AnimalsCarcinoma, HepatocellularEriobotryaGlucoseHep G2 CellsHumansLiver NeoplasmsRatsRats, Sprague-DawleyTriterpenesZebrafishcorosolic acidGlucoseTriterpenes

Identifiers

PMID30867526
PMCPMC6416347
OpenAlexW2921989372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.